BioLife Solutions Inc Analyst Price Targets

Wall Street analyst price targets and consensus rating for BioLife Solutions Inc (BLFS).

Price Target Range — 8 Quarters

Analyst Consensus — 8 Analysts

3Buy

5Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$31Upside to Avg. PT-20.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 10, 2026	Benchmark	Robert Wasserman	Downgrade	Buy→Hold	—
Jul 27, 2026	Stephens & Co.	Helfey Hannah	Downgrade	Overweight→Equal-Weight	$32→$31
Jul 23, 2026	Jefferies	Matthew Stanton	Downgrade	Buy→Hold	$30→$31
Jul 23, 2026	TD Cowen	Brendan Smith	Downgrade	Buy→Hold	$33→$31
Jul 22, 2026	HC Wainwright & Co.	Yi Chen	Downgrade	Buy→Neutral	$32→$31
Jul 22, 2026	Lake Street	Thomas Flaten	Downgrade	Buy→Hold	$33→$31
Dec 29, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$32
Nov 24, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$32
Aug 8, 2025	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$30→$32
May 13, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$30
Mar 6, 2025	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$27→$30
Jan 8, 2025	Northland Capital Markets	Carl Byrnes	PT Raise	Outperform	$28→$31
Dec 19, 2024	Benchmark	Robert Wasserman	Maintained	Buy	$30
Dec 13, 2024	Keybanc	Paul Knight	PT Raise	Overweight	$30→$33
Nov 18, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$29→$27
Nov 13, 2024	TD Cowen	Steven Mah	PT Raise	Buy	$28→$31
Nov 13, 2024	Craig-Hallum	Matt Hewitt	PT Raise	Buy	$30→$32
Sep 30, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Initiate	Buy	$29
Aug 12, 2024	Craig-Hallum	Matt Hewitt	PT Raise	Buy	$23→$30
Aug 9, 2024	Northland Capital Markets	Carl Byrnes	PT Raise	Outperform	$26→$28